Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Palatin Technologies (NY: PTN ) 1.090 UNCHANGED Streaming Delayed Price Updated: 8:00 PM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Palatin Technologies < Previous 1 2 3 4 Next > 10 Health Care Stocks Moving In Monday's Pre-Market Session November 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session October 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 27, 2024 Via Benzinga Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development – Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions August 29, 2024 Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development – Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions Via News Direct Exposures Product Safety Earnings Scheduled For February 15, 2024 February 15, 2024 Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. Via Benzinga Earnings Preview: Palatin Techs February 14, 2024 Via Benzinga Recap: Palatin Techs Q1 Earnings November 14, 2023 Via Benzinga Palatin Techs's Earnings Outlook November 13, 2023 Via Benzinga PTN Stock Earnings: Palatin Techs Misses EPS for Q3 2024 May 15, 2024 PTN stock results show that Palatin Techs missed analyst estimates for earnings per share the third quarter of 2024. Via InvestorPlace Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying April 12, 2024 The Dow Jones index closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... Via Benzinga Topics Stocks Exposures US Equities Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data April 08, 2024 Palatin Technologies unveils Phase 3 PL9643 MELODY-1 trial results for dry eye disease treatment, showcasing statistically significant efficacy in pain reduction and secondary symptoms. PL9643... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 28, 2024 Via Benzinga Palatin Technologies' Disappointing Data From Dry Eye Disease Study, Stock Plummets February 28, 2024 Palatin Technologies' results from PL9643 MELODY-1 Phase 3 trial for dry eye disease. The co-primary endpoints and secondary endpoints did not reach statistical significance. Via Benzinga Earnings Outlook For Palatin Techs September 27, 2023 Via Benzinga Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 28, 2024 Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. Via Benzinga Dow Dips 200 Points; TJX Posts Upbeat Sales February 28, 2024 U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.52% to 38,770.83 while the NASDAQ... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 28, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 15, 2024 Via Benzinga The 3 Best Penny Stocks to Buy in February 2024 February 15, 2024 With proposed FED rate cuts incoming, these are the penny stocks that are likely to see a spark into new rallies. Via InvestorPlace 7 Analyst-Backed Stocks With Promising 10-Bagger Potential February 01, 2024 Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot. Via InvestorPlace 3 Penny Stocks to Buy to Unlock 2,500% Upside Potential January 11, 2024 These penny stocks have triple-digit upside as 2024 brings easing monetary policy and economic normalization. Via InvestorPlace Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc. January 03, 2024 From Cosette Pharmaceuticals, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's Intraday Session December 27, 2023 Via Benzinga Analysts Say 3 Stocks Have a Combined Upside of 3000% December 23, 2023 These high-risk, high-reward bets could be at an inflection point before their growth takes off next year. Via InvestorPlace Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket December 15, 2023 Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session December 15, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday December 15, 2023 It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today! Via InvestorPlace Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders October 19, 2023 EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END Via FinancialNewsMedia Earnings Scheduled For September 28, 2023 September 28, 2023 Companies Reporting Before The Bell • CarMax (NYSE:KMX) is projected to report quarterly earnings at $0.78 per share on revenue of $7.03 billion. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday September 19, 2023 During Tuesday's session, 275 companies made new 52-week lows. Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
